CCNE1 and Familial prostate cancer: TCGA analysis revealed that 85, 81, 89, 86, 93 and 96% of breast, ovarian, pancreatic, lung, colorectal and prostate cancers, respectively, are positive for Rb and have low/no expression of cyclin E (Fig. 6a and Supplementary Fig. 19a).